Nasal-spraying LiveSpo NAVAX: Probiotics of the next generation for respiratory infections
HANOI, VIETNAM - Media OutReach - 15 August 2022 -On July 20nd, the Scientific Reports journal (the Nature) officially annouced a break-through research on using LiveSpo NAVAX probiotic spores in nasal spray form to support the treatment of acute respiratory infections in children infected with respiratory syncytial virus (RSV) [1]
Respiratory syncytial virus (RSV) is a leading cause of Acute Respiratory Tract Infections (ARTIs) in young children.
The World Health Organization estimates that 48,000-74,000 children - younger than five years old die yearly due to RSV infection. Up to now, there is no available vaccine and specific treatment for RSV-infected children.
Researchers at Vietnam National Children’s Hospital conducted the first clinical trial in infected children with Respiratory Syncytial Virus (RSV). They demonstrated the safety and beneficial effects of a nasal-spraying liquid suspension of Bacillus spore probiotics (LiveSpo® NAVAX) in the supportive treatment of ARTIs.
The research team published results showing that the nasal-spraying LiveSpo NAVAX) reduced the load of RSV and influenza virus by 300-fold and 1000-fold, and was 50- to 70-fold more effective than physiological saline after 2-3 days of treatment.
Semi-quantitative real-time PCR results of co-infection bacteria on day three of treatment show that patients in the NAVAX) group (spraying probiotics spores) were negative while patients in the control group (not using probiotic spores) only had a slight decrease in bacterial co-infection concentration.
The team also assessed that the nasal-spraying Bacillus spores could rapidly and effectively relieve symptoms of RSV-induced ARTIs while exhibiting a strong effect in reducing viral load and inflammation.
Nasal-spraying probiotics may provide the basis for simple, low-cost, and effective symptomatic adjuvant treatment against viral infections.
Dr. Nguyen Hoa Anh - Director of Sporebiotics Research Center said: “The interaction mechanism between LiveSpo NAVAX) 's Bacillus spores and the virus and the nasal mucosal immune system is based on nonspecific binding suggesting that LiveSpo Navax may be helpful against viral variants that cause respiratory diseases or other rapidly emerging respiratory viruses such as influenza virus or coronavirus.
The research is a breakthrough scientific achievement, contributing to enhancing the image of Vietnam in the field of science in the international arena and making a great contribution to public health care, especially for children.
[1] Scientific Report (July 20th, 2022). “Nasal‑spraying Bacillus spores as an efective symptomatic treatment for children with acute respiratory syncytial virus infection” https://www.nature.com/articles/s41598-022-16136-z.pdf
Hashtag: #LiveSpo
About LiveSpo
LiveSpo® NAVAX containing more than 5-billion spores of beneficial bacteria Bacillus subtilis and Bacillus clausii, and 0.9% physiological saline up to 5mL.
The product supports to help clean ears, nose, throat; and prevent, reduce the risk of ear, nose, throat infections, and increase beneficial bacteria, protect and the nasal mucosa.
Partnership unlocks card and local payment options for players in Brazil, Mexico, Argentina, Chile, and Peru as the region's gaming revenues outpace mature marketsSINGAPORE / GUANGZHOU, CHINA – Me...
Launch of new products, market expansion and AI-enabled capabilities mark the next stage of growth for a global healthcare technology company anchored by six decades of trusted medical data and exp...
SYDNEY, AUSTRALIA - Media OutReach Newswire - 28 September 2026 - Fairland Group's outdoor technology division, iGarden, announced the launch of the iGarden K70 AI Pool Cleaner, bringing extended ...
Lanson Place Parliament Gardens receives prestigious global accolade of One MICHELIN Key as the Melbourne property marks its second anniversaryHONG KONG SAR – Media OutReach Newswire – 28 Septembe...
HONG KONG SAR – Media OutReach Newswire – 28 September 2026 – Bosera Asset Management (International) Co., Limited ("Bosera International") announced that the Bosera HKEX KRX Semiconductor Index E...
Little Monsters Unleash Their Mischievous CharmHONG KONG SAR - Media OutReach Newswire - 28 September 2026 - Halloween is not just a crazy night for big monsters — cute little monsters can also jo...
Third annual forum co-hosted with Mastercard and FTAHK to explore how AI is reshaping financial servicesHONG KONG SAR – Media OutReach Newswire – 28 September 2026 – As artificial intelligence (AI...
DKSH and Grünenthal have entered into a new regional partnership agreement covering eight Asia-Pacific markets. The collaboration combines Grünenthal’s leadership in pain management with DKSH Healt...
Latest addition to flagship MyLegacy Series offers greater flexibility for legacy planning needs New multi-currency insurance plan adds flexibility with a first-in-market settleme...
SHENZHEN, CHINA – Media OutReach Newswire – 28 September 2026 – On September 24, UnionPay officially released the "Qianhai Smart Payment Service Support Plan for the 2026 APEC 'China Year'," aimed...
For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating enquiries and examine what happens after a custome...
In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...
The Federal Government’s decision to permanently legislate the $20,000 instant asset write-off will give eligible small businesses greater certainty...
The Australian corporate landscape is undergoing a fundamental transformation in how it sources talent and innovation. While businesses have traditi...
